CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In CV Sciences, Inc. (Other OTC: CVSI) To Contact Brower Piven Before The Lead Plaintiff Deadline
STEVENSON, Md., Aug. 27, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of purchasers of CV Sciences, Inc. (Other OTC: CVSI) (“CV Sciences” or the “Company”) securities during the period between June 19, 2017 and August 20, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 23, 2018 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in CV Sciences securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that its Patent #15/426,617 received a non-final rejection from the US Patent Trademark Office (“USPTO”) on April 27, 2017 and a final rejection from the USPTO on December 14, 2017.
According to the complaint, following an August 20, 2018 report exposing the Defendant’s failure to disclose the final rejection of its Patent on December 14, 2017 and the mailed notice of final rejection on December 20, 2017, the value of CV Sciences shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in CV Sciences securities purchased on or after June 19, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at firstname.lastname@example.org or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. PivenBrower Piven, A Professional Corporation1925 Old Valley RoadStevenson, Maryland 21153Telephone: 410-415-6616 email@example.com